showing the working

← Sinovac Biotech

The business behind the dividend

MeasureSVAMedianFormula
Return on equity-4.5%10.6%Net income ÷ shareholders’ equity
Return on capital employed-9.9%10.0%Operating income ÷ (equity + total debt)
Owner earnings$-150.31m$120.90mNet income + depreciation & amortisation − capital expenditure
Free cash flow$-561.10m$155.08mOperating cash flow − capital expenditure
Operating margin-127.0%14.3%Operating income ÷ revenue
Net margin-51.5%10.1%Net income ÷ revenue
Debt to equity0.11x0.73xTotal debt ÷ shareholders’ equity
Interest cover-49.92x4.22xOperating income ÷ interest expense
Current ratio4.59x1.55xCurrent assets ÷ current liabilities
Long-term debt to working capital0.09x1.88xLong-term debt ÷ (current assets − current liabilities)
Cash conversionOperating cash flow ÷ net income
Accruals3.7%-3.1%(Net income − operating cash flow) ÷ total assets

Not computed here: Cash conversion — why a blank is not a zero.

Ten years of it

The same measures, for every year the filings support. One year is a fact; a row is a business.

Measure2025202420232022202120202019201820172016Median
Return on equity-4.5%0.5%-0.2%0.2%90.3%14.8%15.3%8.6%17.1%-0.5%0.5%
Return on capital employed-9.9%-5.9%-8.3%-6.0%195.5%27.6%22.9%17.2%22.4%0.3%0.3%
Operating margin-127.0%-139.9%-151.9%-34.5%91.0%42.2%27.9%19.7%26.0%0.7%0.7%
Net margin-51.5%11.3%-2.9%1.0%41.9%21.6%18.3%9.5%14.8%-0.8%9.5%
Debt to equity0.11x0.05x0.03x0.00x0.00x0.05x0.02x0.04x0.34x0.62x0.04x
Current ratio4.59x7.33x8.97x9.00x5.93x2.30x4.01x4.88x2.20x1.97x4.59x
Cash conversion-1.40x1.89x4.34x0.87x0.36x2.32x0.87x